Sanofi, GSK launch Phase III trial for their COVID-19 shot

Pending positive phase III outcome, the vaccine could be approved in the fourth quarter 2021 after having initially been targeted for the first half of this year before a setback.

from International-News-Economic Times https://ift.tt/3uwsHqM
via IFTTT

SHARE